Today: 13 June 2026
Browse Category

Stock Market 16 November 2025

AstraZeneca (AZN) Share Price: What to Know Before London Market Opens on 17 November 2025

AstraZeneca (AZN) Share Price: What to Know Before London Market Opens on 17 November 2025

AstraZeneca closed near record highs in London on Friday, 14 November, at about 13,532p, valuing the company near £210bn. Q3 revenue rose 10% to $15.2bn, beating forecasts, but full-year guidance was unchanged. Shareholders approved a direct NYSE listing, set for February 2026. The company reported 16 positive Phase III trials and 31 regulatory approvals so far this year.
16 November 2025
Lloyds Share Price: Can the FTSE‑100 Bank’s Value Keep Surging or Is a Crash Coming?

Lloyds (LON:LLOY) Share Price: Curve Deal, BoE Rates and Scandal Risks to Watch Before the 17 November 2025 Open

Lloyds Banking Group shares closed at 91.74p on Friday, down 2.78% after hitting a 52-week high of 95.70p earlier in the week. The stock faces pressure from a £120m fintech acquisition, a £1.7bn buyback, and ongoing scandals as investors await the London open on Monday. The FTSE 350 banks index fell 2.2% amid global growth concerns and UK budget uncertainty.
16 November 2025
CBA (ASX:CBA) before the bell: What to know about Commonwealth Bank of Australia stock ahead of the ASX open on 17 Nov 2025

CBA (ASX:CBA) before the bell: What to know about Commonwealth Bank of Australia stock ahead of the ASX open on 17 Nov 2025

CBA shares closed at A$157.30 Friday, down 10% for the week after the bank’s quarterly update flagged margin pressure despite reporting A$2.6bn cash NPAT for the September quarter, up 2% year-on-year. The sell-off followed commentary on net interest margins and came as CBA’s premium valuation left it exposed to rotation into cheaper peers. CET1 ratio stood at 11.8% on 30 September. The bank did not disclose a headline NIM figure.
16 November 2025
Westpac (ASX: WBC) before the bell — What to know for Monday, 17 Nov 2025

Westpac (ASX: WBC) before the bell — What to know for Monday, 17 Nov 2025

Westpac extended its regional branch closure moratorium to 2030 and will trial a new community banking service. The bank reported FY25 statutory net profit of A$6.9bn and raised operating expenses 9% to A$11.9bn. On-market buyback capacity remains up to A$3.5bn, with the next phase set for November 2025. Westpac has back-paid nearly 47,000 staff over A$50m after underpayments.
16 November 2025
BHP Group (ASX: BHP) pre‑open briefing for Monday, 17 Nov 2025: UK dam ruling fallout, China iron‑ore tensions, and overnight cues

BHP Group (ASX: BHP) pre‑open briefing for Monday, 17 Nov 2025: UK dam ruling fallout, China iron‑ore tensions, and overnight cues

A UK High Court found BHP liable under Brazilian law for the 2015 Fundão dam collapse; damages will be set later, with BHP planning to appeal. BHP’s NYSE ADRs closed down 1.3% at $55.23 Friday. Iron ore traded at $103–104/t, with Dalian futures slightly higher. The Australian dollar hovered near 0.65 USD late last week.
Newcrest Mining Stock in 2025: What ASX Investors Must Know About Newmont (ASX:NEM) Before the Market Opens on 17 November

Newcrest Mining Stock in 2025: What ASX Investors Must Know About Newmont (ASX:NEM) Before the Market Opens on 17 November

Newcrest Mining Limited (ASX:NCM) no longer trades on the ASX after its acquisition by Newmont in 2023. Newmont CHESS Depositary Interests began trading under the code NEM from 27 October 2023, with Newcrest shareholders receiving 0.4 Newmont securities per share. Newcrest was formally delisted on 8 November 2023. Key former Newcrest mines now operate under Newmont’s portfolio.
16 November 2025
Telstra (ASX: TLS) Stock Outlook: What to Know Before the ASX Opens on 17 November 2025

Telstra (ASX: TLS) Stock Outlook: What to Know Before the ASX Opens on 17 November 2025

Telstra shares closed at A$4.94 on Friday, down 0.6%, with volume at 15.5 million, below average. The stock sits near the top of its 52-week range and has gained about 25–30% over the past year. Telstra’s A$1 billion buy-back, launched in September, has seen over 57.8 million shares repurchased so far. Market cap stands near A$56 billion, with a dividend yield around 3.8–3.9%.
16 November 2025
Wesfarmers (ASX: WES) Share Price: What Investors Need to Know Before the ASX Opens on 17 November 2025

Wesfarmers (ASX: WES) Share Price: What Investors Need to Know Before the ASX Opens on 17 November 2025

Wesfarmers closed at A$81.13 on Friday, down 0.44%, after reporting record FY25 revenue of A$45.7 billion and net profit of A$2.93 billion. A A$1.50 per share capital return and special dividend are set for 4 December. Shares have gained 20–30% year-to-date but now trade at a price-to-earnings ratio of 35.6x, well above most Australian peers.
16 November 2025
DroneShield (ASX:DRO): 10 Things Investors Need to Know Before the ASX Opens on 17 November 2025

DroneShield (ASX:DRO): 10 Things Investors Need to Know Before the ASX Opens on 17 November 2025

DroneShield shares closed at A$2.33 on Friday, up 3.56% after a volatile week that saw the stock drop up to 40%. The company’s market cap stands near A$2 billion, down from a 52-week high of A$6.70. Shares surged over 300% year-to-date before a sharp sell-off triggered by new share issuance and questions over a reported A$7.6 million contract.
Nasdaq Frenzy: Tech Titans’ AI-Fueled Surge Hits Records Ahead of Fed Cut & Earnings Bonanza

China Stocks: What to Know Before the Open on November 17, 2025 — PBOC’s ¥800bn Liquidity Boost Meets Global Risk-Off

The People’s Bank of China will inject ¥800 billion into the financial system Monday, a net ¥500 billion boost after maturities, as A-shares reopen following a global tech-led selloff. October data showed industrial output up 4.9% year-on-year, but retail sales slowed and real estate investment fell 14.7%. New-home prices dropped 0.5% in October, the steepest monthly decline in a year. FTSE China A50 futures fell 1.33% Friday.
16 November 2025
Tokyo Stock Exchange Surges to Record Highs on AI Boom – Inside the Nov 3, 2025 Rally

Japan Stocks Today: What to Know Before the Tokyo Open (Nov 17, 2025) — GDP at 8:50 JST, Yen Near 154, Stimulus in Focus

Japan’s Q3 GDP estimate, due at 8:50 a.m. JST, is expected to show a 0.6% quarterly contraction, minutes before Tokyo’s cash equity open. CME Nikkei 225 futures rose 0.7% late Sunday, signaling a steadier start after Friday’s 1.77% drop. The dollar/yen hovered near 154.5, with officials warning against sharp FX moves. Finance Minister Katayama said stimulus will exceed ¥17 trillion, with cabinet approval eyed for Nov 21.
16 November 2025
Palantir (PLTR) Stock Forecast: AI-Fueled Surge, Q3 Earnings Blowout & 2025 Outlook

Palantir Stock (PLTR) on November 17, 2025: What You Need to Know Before the Market Opens

Palantir shares closed at $174.01 on Friday, up 1.1% after volatile trading and heavy volume. The stock has dropped 16% from its November 3 record near $207.52, but remains up over 100% for the year. Q3 revenue surged 63% to about $1.2 billion, prompting the company to raise full-year guidance again. High-profile short sellers, including Michael Burry, have targeted the stock.
16 November 2025
Cisco’s $2B AI Windfall: New Tech, Stock Surge & What’s Next for CSCO

Cisco (CSCO) Stock Near Dot‑Com Highs: What to Know Before the Market Opens on November 17, 2025

Cisco Systems closed Friday at $78.00, its highest finish since the early 2000s and just below its 52-week intraday high of $79.50. Fiscal Q1 2026 revenue rose 8% to $14.9 billion, beating estimates, and the company raised its full-year outlook. Cisco reported $1.3 billion in Q1 AI infrastructure orders and expects $3 billion in AI revenue for fiscal 2026. The stock is up over 30% year-to-date.
16 November 2025

Stock Market Today

  • CSL Shares Rise 9.8% After FY26 Guidance Cut on Impairments and Channel Shifts
    June 13, 2026, 5:50 AM EDT. CSL (ASX:CSL) shares climbed 9.8% following a downward revision of its FY26 revenue and profit forecasts. The revision reflects impairments and writedowns linked to changes in U.S. immunoglobulin sales channels and weakening albumin prices in China. Despite these challenges, investor sentiment shows cautious optimism about CSL's operational turnaround prospects. The market now awaits CSL's full-year results and dividend update on 18 August 2026, which will offer clarity on revenue trends and any further impairments. CSL projects FY29 revenue of US$16.9 billion and earnings of US$3.3 billion, suggesting a potential 31% upside to current share prices. However, risks remain around sustained margin pressure and additional write-downs in plasma and albumin segments.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 13.06.2026

13 June 2026
LIVEMarkets rolling coverageStarted: June 13, 2026, 4:00 AM EDTUpdated: June 13, 2026, 5:59 AM EDT CSL Shares Rise 9.8% After FY26 Guidance Cut on Impairments and Channel Shifts June 13, 2026, 5:50 AM EDT. CSL (ASX:CSL) shares climbed 9.8% following a downward revision of its FY26 revenue and profit forecasts. The revision reflects impairments and writedowns linked to changes in U.S. immunoglobulin sales channels and weakening albumin prices in China. Despite these challenges, investor sentiment shows cautious optimism about CSL’s operational turnaround prospects. The market now awaits CSL’s full-year results and dividend update on 18 August 2026, which will offer
SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

13 June 2026
SGH closed at A$41.51, up 0.70% but underperformed the S&P/ASX 200’s 1.98% surge, as investors weighed solid cash flow and Boral margin gains against a high 36.03 P/E, mixed demand, and M&A risk; the next key catalyst is FY26 results on August 11, with analysts’ average target at A$47.64, 14.76% above Friday’s close.
Go toTop